Bonacina E, Armengol-Alsina M, Garcia-Manau P, López M, Rodriguez-Zurita A, Vives À, Lopez-Quesada E, Ricart M, Maroto A, de Mingo L, Pintado E, Arias-Garcia A, Martín L, Chulilla-Pérez C, Garcia E, Pallarols M, Vidal-Sagnier L, Teixidor M, Orizales-Lago C, Pérez-Gomez A, Ocaña V, Puerto L, Millán P, Diaz S, Del Barco E, Dalmau M, Rolle V, Carreras E, Suy A, Mendoza M
Aspirin Discontinuation at 24-28 Weeks and Placental Biomarker Trajectories: Post Hoc Analysis of a Randomised Trial.
Moskal A, Myrczek R, Wawro M, Auladell LR, Baiges A, Garcia I, Gonzalez FM, Pujana MA, Kochan J, Hinz A, Radzikowska E, Lucas S, Bereta J, Mezyk-Kopec R
Autocrine TGF-ß signaling promotes cell motility and chemokine secretion in an angiomyolipoma-derived cell model of lymphangioleiomyomatosis.
Mateos, MV, Paiva, B, Cedena, MT, Puig, N, Sureda-Balari, AM, de la Calle, VG, Oriol, A, Ocio, EM, Rosiñol, L, Montes, YG, Bargay, J, García, MEG, Lakhwani, S, Payer, AR, Suarez-Cabrera, A, Blanchard, MJ, Garzón, S, Montero, FC, Cabañas, V, Oteyza, JPD, Gironella, M, Martinez-Lopez, J, Casasús, AIT, Delgado-Beltrán, MP, Prieto, E, Lahuerta, JJ, Bladé, J, San-Miguel, J
Induction therapy with bortezomib, melphalan, and prednisone followed by lenalidomide and dexamethasone versus carfilzomib, lenalidomide, and dexamethasone with or without daratumumab in older, fit patients with newly diagnosed multiple myeloma (GEM-2017FIT): a phase 3,-label, multicentre, randomised clinical trial
Vener, C, Lillini, R, De Angelis, R, Bonfarnuzzo, S, Poirel, HA, Trama, A, Visser, O, Troussard, X, Marcos-Gragera, R, Maynadié, M, Demuru, E, Di Benedetto, C, Johannesen, TB, Solans, M, Paapsi, K, Guevara, M, Mousavi, SM, Blum, M, Von Moos, R, Bennett, D, Ragusa, R, Guilloteau, A, Mcshane, CM, Rossi, S, Sant, M
Long-term survival for myeloid neoplasms and national health expenditure: A EUROCARE-6 retrospective, population-based study
Pla H, Fullana B, Esteve A, Fort-Culillas R, Ferrando-Díez A, Fernández-Ortega A, Pous A, Stradella A, Villanueva-Vázquez R, Cirauqui B, Falo C, Martínez-Pérez E, Molina G, Del Barco S, Eraso A, Margelí M, Viñas G, Gil-Gil M, Petriz L, Pernas S
Comprehensive Clinical Characterization and Long-Term Follow-Up of the Institut Català d'Oncologia Breast Cancer Observational Cohort Study.
Pérez-Lamas L, Segura Diaz A, García Delgado R, Álvarez-Larrán A, Senin MA, Mora E, Fox ML, Pastor Galan I, Azaceta G, Garrido Paniagua S, Pérez Lopez R, Trejos Carvajal DM, Angona A, Albo López C, Lorente Alegre P, Vara M, Vera Goñi JA, De Miguel Llorente D, Fernández Rodríguez Á, Marín Sanchez A, Hernando Megido A, Gómez Casares MT, Stuckey R, Carreño-Tarragona G, De Las Heras Rodriguez N, Xicoy B, Pérez Encinas M, Mata Serna R, Núñez Martin-Buitrago L, Ferrer Marín F, Amer Salas N, Guillén Rienda C, Velez P, Lamarca Eraso L, Martín S, Luts Khoroz I, De Cabo López E, Gil A, Martín-Consuegra Ramos S, Marco De Lucas F, Otero Martinez-Fornes MJ, Martín Mateos ML, Arquero T, Cabezudo Pérez E, López Gómez LA, Martínez Hellin Á, Tejedor A, Herrera de Pablo E, Mata Vazquez MI, Castillo Valero I, Fernández MJ, Aguilar C, Santaliestra M, García Menchon A, Navas Elorza B, Duran MA, Pérez Sala M, Hernández Santamaría T, Muñoz Jarreño MÁ, Dávila-Valls J, Torres Jiménez W, Gonzálvez Fernández JA, Torres Mantilla HA, Cobo Rodríguez T, Abuin Blanco A, Pérez F, Osorio Prendes S, Beneit Villena P, Peralta R, Herrera F, Cañamero Giro E, Jiménez Bárcenas R, Gasior Kabat M, González De Villambrosia S, Tercero-Mora Rodriguez MT, Menéndez Cuevas M, Cuevas Ruiz B, Fonseca-Santos M, Garcés Piquer S, De La Puerta R, Lorenzo Vizcaya Á, Hernández Boluda JC, García Gutiérrez V
Real world outcomes of momelotinib in myelofibrosis patients with anemia: results from the MOMGEMFIN study.
Santos-Pujol E, Noguera-Castells A, Casado-Pelaez M, García-Prieto CA, Vasallo C, Campillo-Marcos I, Quero-Dotor C, Crespo-García E, Bueno-Costa A, Setién F, Ferrer G, Davalos V, Mereu E, Pluvinet R, Arribas C, Torre C, Villavicencio F, Sumoy L, Granada I, Coles NS, Acha P, Solé F, Mallo M, Mata C, Peregrina S, Gabaldón T, Llirós M, Pujolassos M, Carreras-Torres R, Lluansí A, García-Gil LJ, Aldeguer X, Samino S, Torné P, Ribalta J, Guardiola M, Amigó N, Yanes O, Martínez P, Sánchez-Vázquez R, Blasco MA, Oviedo J, Lemos B, Rius-Bonet J, Torrubiano M, Massip-Salcedo M, Khidir KA, Cao TH, Quinn PA, Jones DJL, Macip S, Brigos-Barril E, Moldes M, Barteri F, Muntané G, Laayouni H, Navarro A, Esteller M
The multiomics blueprint of the individual with the most extreme lifespan.
Lluch A, Latorre J, Espadas I, Oliveras-Cañellas N, Moreno-Navarrete JM, Caballano-Infantes E, Sarker G, Malvido NF, Garrido-Gil P, Labandeira-García JL, Nakaya N, Mora S, Chicano E, López-Alcalá J, Malagón MM, Martín-Montalvo A, Zhang B, Zhou Y, Domingos AI, López M, Pörschke J, Gómez-Serrano M, Szymanski W, Graumann J, Tomarev SI, González-García I, Fernández-Real JM, Ortega FJ
Defective Olfactomedin-2 connects adipocyte dysfunction to obesity.
Serra, I, Romaguera, A, Clos, A, Valenzuela, M, Bartrolí, B, Espin, G, Núñez, CL, Guardeño, R, Trallero, J, Puigdemont, M, Sanvisens, A, Sala, M, Marcos-Gragera, R
Population study of hepatocellular carcinoma survival in northest region of Spain
Jimenez-Trinidad, FR, Solanes, N, Arrieta, M, Llonch, B, Roque, M, Freixa, X, Brugaletta, S, Ortega-Paz, L, Rodriguez, JJ, Cepas-Guillen, P, Vilhaur, G, Sabate, M, Dantas, AP, Tura-Ceide, O, Rigol, M
Myocardial infarction induces endothelial dysfunction with independence of cardiovascular risk factors
